William Cromwell, Md, Faha, Fnla Email & Phone Number

Durham, North Carolina, Us

Summary:I developed the Lipoprotein and Metabolic Disorders Institute (LMDI) as a center of excellence for:1. Comprehensive evaluation and management of lipoprotein disorders affecting patients of all ages2. Non-invasive imaging of early vascular disease;3. Educational institute for research and teaching in the cardiometabolic space. Specific responsibilities:1. Evaluation and management of genetic and acquired disorders of lipid (cholesterol and triglycerides) and lipoprotein (particles that transport cholesterol and triglycerides) metabolism.2. Noninvasive imaging to identify subclinical atherosclerotic cardiovascular disease.3. Lipoprotein research focused on the relationship of various biomarkers with cardiometabolic disease.4. National key opinion leader in lipoprotein and metabolic disorders. In this role, my activities include: - Presentation of invited CME and grand round lectures in academic institutions; - Publication of peer-reviewed original research, as well as invited reviews/book chapters; - Presentation of non-CME speaking for selected companies; - Consulting and clinical advisory boards work for selected companies.

Little Rock, Arkansas, Us

Summary:Precision Health Reports is a digital health company that combines an individual's comprehensive clinical history, biometrics, outcome-proven biomarkers, and various clinical guideline recommendations to produce actionable patient-specific reports. Our Cardiometabolic Risk Report answers the questions "What is MY risk for developing diabetes, heart attack, or stroke, and what can I do to reduce MY risk?".Specific Responsibilities:1. Co-founder with fiduciary responsibilities for company growth and performance.2. Chief Medical Officer with oversight of product development. Responsibilities include: - Product development and clinical messaging - Management of KOL relationships - Liaison with external organizations and medical societies3. Peer-to-peer support for providers regarding report interpretation and clinical management of individual patients.

Burlington, North Carolina, Us

Summary:I worked cross-functionally in a matrixed environment to lead cardiometabolic business development evaluations, manage clinical relations with commercial and government payors, external relationships with KOLs and clients, and clinically support NMR analyte development. I also worked with the Chief Scientific Officer, Chief Medical Officers, and senior management to ensure alignment and execution of strategic priorities.Specific Responsibilities:1. Lead LabCorp's cardiometabolic clinical initiatives with external organizations. 2. Lead the Cardiovascular Business Advisory Team. Activities included: - Evaluation of technologies for potential licensing or acquisition; - Optimization of LabCorp's biomarker portfolio for evaluation and management of cardiometabolic risk; - Developing strategies to optimize utilization of outcome proven cardiometabolic biomarkers;3. Working with LabCorp's Global Research and Development team, I provided: - Clinical oversight for the development of new laboratory-developed tests (LDT) using NMR cardiovascular biomarkers; - Data analysis and interpretation for academic, government, and industry research collaborators; - Clinical support for FDA 510K submission of new biomarkers; - Clinical support for external academic, government, and industry collaborators.4. Collaborate with marketing and managed care leadership to refine clinical positioning for cardiometabolic biomarkers.5. Manage relationships with academic and community cardiometabolic key opinion leaders.6. Respond to clinical inquiries regarding cardiometabolic biomarker interpretation for LabCorp customers and the LabCorp field sales force.7. Support the Chief Medical Officer, Chief Science Officer, and senior management team with strategies for properly utilizing cardiometabolic biomarkers.8. Present CPT submissions to CMS for approval of new codes and payment for proprietary cardiometabolic biomarkers.

Summary:As a member of senior management, I worked cross-functionally in a matrixed environment to lead medical affairs, clinical relations with commercial and government payors, external relationships with KOLs and clients, and clinical support for global research & development. I also worked with the Board of Directors to ensure alignment and execution of strategic priorities related to the clinical utilization of propriety nuclear magnetic resonance (NMR) biomarkers.Specific responsibilities:1. Timely production of clinical deliverables to achieve commercial objectives and strategic goals.2. Lead clinical relationships with commercial and government payors to optimize utilization and reimbursement of LipoScience's proprietary NMR biomarkers in appropriate patient populations. 3. Medical liaison to external organizations, including provider groups, accountable care organizations, and medical specialty societies regarding clinical utilization of LipoScience biomarkers.4. Clinical support for LipoScience's Global Research and Development team on projects including: - Development of new laboratory-developed tests (LDT) using proprietary NMR biomarkers; - Data analysis and interpretation for research collaborators; - Publishing peer-reviewed research and invited expert reviews of NMR biomarkers; - Clinical support and FDA presentations for 510K submission of new biomarkers; - Clinical interactions with external academic, government, and industry collaborators.5. Work cross-functionally with sales and marketing to optimize representative training, customer support, and business development7. Develop clinical messaging, direct speaker training/support, and management of KOL relationship.8. Training and management of the LipoScience's Medical Science Liaisons (MSL) team.9. Peer-to-peer support for providers regarding LipoScience biomarker interpretation and clinical management of individual patients.10. LabCorp acquired LipoScience in November 2014.

1. Clinical:As part of the Novant Heart and Wellness program (previously the Presbyterian Center for Preventive Cardiology), I established this practice as a center of excellence for the comprehensive evaluation and management of lipoprotein disorders affecting patients of all ages, as well as a center of excellence for non-invasive imaging of early vascular disease. 2. Educational:I served as a national key opinion leader in lipoprotein and metabolic disorders. In this role, my activities include: - Presentation of invited CME and grand round lectures in academic institutions; - Publication of peer-reviewed original research, as well as invited reviews/book chapters; - Consulting and clinical advisory board work for selected companies.

1. I led the development of system-wide clinical practice standards of care for cardiovascular disease prevention involving 8 specialty clinics in the Novant network.2. I directed activities to develop the Division of Lipoprotein and Metabolic Disorders as a national center of excellence in lipoprotein disorders. Activities included: - Supervision of division research centers; - Principal investigator for multiple clinical trials; - Publication of peer-reviewed original research; - Participation in invited CME and non-CME lectures.

1. Clinical:I joined the Presbyterian Center for Preventive Cardiology to establish a center of excellence for the comprehensive evaluation and management of lipoprotein disorders. 2. Educational:I served as a national key opinion leader in lipoprotein and metabolic disorders. In this role, my activities include: - Presentation of invited CME and grand round lectures in academic institutions; - Publication of peer-reviewed original research, as well as invited reviews/book chapters; - Presentation of non-CME speaking for selected companies; - Consulting and clinical advisory board work for selected companies.

I led the development of a center of excellence for management lipoprotein disorders within the Presbyterian Center for Preventive Cardiology. Activities included: - Supervision of division research centers; - Principal investigator for multiple clinical trials; - Publication of peer-reviewed original research; - Participation in invited CME and non-CME lectures.

1. As a member of senior management, I provided leadership in all matters related to the clinical utility of LipoScience's propriety nuclear magnetic resonance (NMR) biomarkers.2. I was responsible for clinical message development, KOL relationships, and speaker training/support. 3. I provided clinical presentations and support for LipoScience's 510K FDA applications.4. I published clinical manuscripts and delivered presentations to commercial and government payors to optimize reimbursement for LipoScience's proprietary NMR biomarkers. 5. I provided clinical oversight and support for LipoScience's Global Research and Development team on projects including: - New biomarker discovery and clinical validation; - Data analysis and interpretation for research collaborators; - Publishing peer-reviewed research and invited expert reviews of NMR biomarkers; - Clinical support for FDA submission of new biomarkers; - Clinical interactions with external academic, government, and industry collaborators.6. I responded to clinical questions from providers regarding NMR biomarker interpretation and clinical evaluation, and management of individual patients.7. I led LipoScience's clinical initiatives with external organizations, including provider groups, accountable care organizations, and medical specialty societies.

1. Clinical:In partnership with Paul Ziajka, MD, PhD we established the Florida Lipid Institute as a center of excellence for the comprehensive evaluation and management of lipoprotein disorders affecting patients of all ages. 2. Educational:I serve as a national key opinion leader in lipoprotein and metabolic disorders. In this role, my activities include: - Presentation of invited CME and grand round lectures in academic institutions; - Publication of peer-reviewed original research, as well as invited reviews/book chapters; - Presentation of non-CME speaking for selected companies; - Consulting and clinical advisory board work for selected companies.

1. Clinical:I established a clinical practice focused on the comprehensive evaluation and management of lipoprotein disorders affecting patients of all ages. 2. Educational:I served as a national key opinion leader in lipoprotein and metabolic disorders. In this role, my activities include: - Presentation of invited CME and grand round lectures in academic institutions; - Presentation of non-CME speaking for selected companies.

In this role, I served as a physician in the 807th Mobile Army Surgical Hospital, providing medical wellness examinations and supervising soldier readiness standards.I was called to active duty for Operation Desert Shield / Desert Storm and was awarded the Bronze Star for meritorious service in the theater of operation.

I established one of the first private practice lipid clinics in the United States dedicated to the comprehensive evaluation and management of lipoprotein disorders affecting patients of all ages.

Louisville, Ky, Us

I served as a volunteer faculty member for students and residents in Family Medicine at the Trover Clinic Foundation.

I served as Associate Director of the Family Medicine Residency Program at the Trover Clinic Foundation.

Md, Medicine

Ba, Chemistry

Education record